Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · CFR · Title 21 — Food and Drugs · Part 884 — Obstetrical and Gynecological Devices · § 884.6195

§ 884.6195. Assisted Reproduction Embryo Image Assessment System.

295 words·~1 min read·/us/cfr/t21/s§ 884.6195·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

(a)Identification. An Assisted Reproduction Embryo Image Assessment System is a prescription device that is designed to obtain and analyze light microscopy images of developing embryos. This device provides information to aid in the selection of embryo(s) for transfer when there are multiple embryos deemed suitable for transfer or freezing.
(b)Classification. Class II (special controls). The special control(s) for this device are:
(1)Clinical performance testing must demonstrate a reasonable assurance of safety and effectiveness of the device to predict embryo development. Classification performance (sensitivity and specificity) and predictive accuracy (Positive Predictive Value and Negative Predictive Value) must be assessed at the subject and embryo levels.
(2)Software validation, verification, and hazard analysis must be provided.
(3)Non-clinical performance testing data must demonstrate the performance characteristics of the device. Testing must include the following:
(i)Total light exposure and output testing;
(ii)A safety analysis must be performed based on maximum (worst-case) light exposure to embryos, which also includes the safety of the light wavelength(s) emitted by the device;
(iii)Simulated-use testing;
(iv)Mouse Embryo Assay testing to assess whether device operation impacts growth and development of mouse embryos to the blastocyst stage;
(v)Cleaning and disinfection validation of reusable components;
(vi)Package integrity and transit testing;
(vii)Hardware fail-safe validation;
(viii)Electrical equipment safety and electromagnetic compatibility testing; and
(ix)Prediction algorithm reproducibility.
(4)Labeling must include the following:
(i)A detailed summary of clinical performance testing, including any adverse events;
(ii)Specific instructions, warnings, precautions, and training needed for safe use of the device
(iii)Appropriate electromagnetic compatibility information;
(iv)Validated methods and instructions for cleaning and disinfection of reusable components; and
(v)Information identifying compatible cultureware and explain how they are used with the device. [80 FR 10332, Feb. 26, 2015]
Connections1 cite this
Cited by 1 section
Citation graph
cites case law
§ 884.6195
Assisted Reproduction Embryo Image Assessment System.
Fed. Reg.×1
Cites 0Cited by 1 across 1 source
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.